Regulation of the BRCA1 gene by an SRC3/53BP1 complex

被引:7
|
作者
Corkery, Dale [1 ,2 ,3 ]
Thillainadesan, Gobi [1 ,2 ,3 ]
Coughlan, Niamh [1 ,2 ,3 ]
Mohan, Ryan D. [4 ]
Isovic, Majdina [1 ,2 ,3 ]
Tini, Marc [4 ]
Torchia, Joseph [1 ,2 ,3 ]
机构
[1] London Reg Canc Program, Dept Oncol, London, ON N6A 4L6, Canada
[2] Lawson Hlth Res Inst, London, ON N6A 4L6, Canada
[3] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6G 2V4, Canada
[4] Univ Western Ontario, Dept Physiol & Pharmacol, Siebens Drake Med Res Inst, Schulich Sch Med & Dent, London, ON N6G 2V4, Canada
来源
BMC BIOCHEMISTRY | 2011年 / 12卷
基金
加拿大健康研究院;
关键词
HUMAN BREAST-CANCER; DNA-DAMAGE RESPONSE; TRANSCRIPTIONAL COACTIVATOR; SRC-3/AIB1; COACTIVATOR; MESSENGER-RNA; RECEPTOR; 53BP1; AIB1; ACTIVATION; PROTEINS;
D O I
10.1186/1471-2091-12-50
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Steroid Receptor coactivator 3(SRC3) is an oncogene and a member of the SRC family of nuclear receptor coactivator proteins that mediate the transcriptional effects of nuclear hormone receptors as well as other transcription factors. Results: We have used protein purification and mass spectrometry to identify the 53BP1 tumour suppressor as a novel SRC3-associated protein. Copurification was demonstrated using multiple antibodies, and was not dependent on DNA damage suggesting that SRC3 is not directly involved in the DNA damage response. However using chromatin immunoprecipitation(ChIP) and siRNA knockdown, we have demonstrated that both SRC3 and 53BP1 co-occupy the same region of the BRCA1 promoter and both are required for BRCA1 expression in HeLa cells. Conclusions: Our results suggest that both 53BP1 and SRC3 have a common function that converge at the BRCA1 promoter and possibly other genes important for DNA repair and genomic stability.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] 53BP1 is a positive regulator of the BRCA1 promoter
    Rauch, T
    Zhong, XY
    Pfeifer, GP
    Xu, XZ
    CELL CYCLE, 2005, 4 (08) : 1078 - 1083
  • [2] Loss of 53BP1 Is a Gain for BRCA1 Mutant Cells
    Kass, Elizabeth M.
    Moynahan, Mary Ellen
    Jasin, Maria
    CANCER CELL, 2010, 17 (05) : 423 - 425
  • [3] Differences in 53BP1 and BRCA1 regulation between cycling and non-cycling cells
    Croke, Monica
    Neumann, Martin A.
    Grotsky, David A.
    Kreienkamp, Ray
    Yaddanapudi, Sree C.
    Gonzalo, Susana
    CELL CYCLE, 2013, 12 (23) : 3629 - 3639
  • [4] Comparison of BRCT domains of BRCA1 and 53BP1: A biophysical analysis
    Ekblad, CMS
    Friedler, A
    Veprintsev, D
    Weinberg, RL
    Itzhaki, LS
    PROTEIN SCIENCE, 2004, 13 (03) : 617 - 625
  • [5] Cell cycle-dependent inhibition of 53BP1 signaling by BRCA1
    Feng, Lin
    Li, Nan
    Li, Yujing
    Wang, Jiadong
    Gao, Min
    Wang, Wenqi
    Chen, Junjie
    CELL DISCOVERY, 2015, 1
  • [6] Synthetic lethality and viability: how does BRCA1 interact with 53BP1?
    Morris, Jo
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (01) : 178 - 178
  • [7] BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability
    Aly, Amal
    Ganesan, Shridar
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2011, 3 (01) : 66 - 74
  • [8] 53BP1 and BRCA1 control pathway choice for stalled replication restart
    Xu, Yixi
    Ning, Shaokai
    Wei, Zheng
    Xu, Ran
    Xu, Xinlin
    Xing, Mengtan
    Guo, Rong
    Xu, Dongyi
    ELIFE, 2017, 6
  • [9] Cell cycle-dependent inhibition of 53BP1 signaling by BRCA1
    Lin Feng
    Nan Li
    Yujing Li
    Jiadong Wang
    Min Gao
    Wenqi Wang
    Junjie Chen
    Cell Discovery, 1
  • [10] Complex regulation of the BRCA1 gene
    Xu, CF
    Chambers, JA
    Solomon, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (34) : 20994 - 20997